
Opinion|Videos|September 23, 2024
Treatment Options to Manage and Prevent Relapses in NMOSD
Author(s)Jacqueline Nicholas, MD, MPH
Jacqueline Nicholas, MD, MPH, discusses available treatment options for NMOSD, including management of acute phases, relapses, and symptom control, as well as how both traditional and newer therapies address different aspects of NMOSD pathophysiology.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What treatment options are available for NMOSD (Kümpfel 2024)?
- Discuss options available for treatment of the acute phase and relapses and prevention of relapses.
- Discuss the management of symptoms.
- How do the traditional and newer treatments target various aspects of NMOSD pathophysiology?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Roche Unveils PrevenTRON, a Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High Risk of Alzheimer Decline
2
Alzheimer's Association Launches PROTECT-Cog Combination Prevention Trial
3
Sanofi's Oral TREM2 Agonist SAR448851 Advances to Phase 2 TREMHANCE Trial in Early Alzheimer Disease
4
Building the Foundation for Earlier Alzheimer Disease Diagnosis
5















